OSCR
Oscar Health, Inc.
Oscar Health, Inc. insider trading
Oscar Health, Inc. files with the SEC as a Hospital & Medical Service Plans company headquartered in New York, NY. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.
From SEC filings
Recent OSCR insider transactions
7 insiders traded OSCR on the open market between Jun 23, 2026 and Sep 18, 2026 — 24 sales worth $125.2M, of which 21 were pre-scheduled under a 10b5-1 plan.
- Bought
- —
- Sold
- $125.2M
- Net
- −$125.2M
- Insiders
- 7
21 of 24 on a 10b5-1 plan
Wittman Vanessa Ames10b5-1
Director
−$806K
Sep 18, 2026
25,000 sh · $32.24
Liang Janet10b5-1
President, Oscar Insurance
−$325.8K
Sep 03, 2026
10,360 sh · $31.45
Baltrus Victoria10b5-1
Chief Accounting Officer
−$30.1K
Sep 03, 2026
958 sh · $31.45
Blackley Richard Scott10b5-1
Chief Financial Officer
−$907.9K
Sep 03, 2026
28,869 sh · $31.45
McAnaney Adam10b5-1
Chief Legal Officer
−$285.9K
Sep 03, 2026
9,092 sh · $31.45
Schlosser Mario10b5-1
Director
−$988.2K
Sep 03, 2026
31,422 sh · $31.45
Schlosser Mario
Director
−$4.6M
Aug 28, 2026
150,000 sh · $30.79
Schlosser Mario
Director
−$18.2M
Aug 27, 2026
600,000 sh · $30.34
Blackley Richard Scott
Chief Financial Officer
−$595.1K
Aug 18, 2026
18,750 sh · $31.74
Schlosser Mario10b5-1
Director
−$106.2K
Jul 01, 2026
3,600 sh · $29.50
Schlosser Mario10b5-1
Director
−$421.1K
Jul 01, 2026
13,672 sh · $30.80
Schlosser Mario10b5-1
Director
−$956.7K
Jul 01, 2026
30,228 sh · $31.65
Bertolini Mark T10b5-1
Chief Executive Officer · Director
−$13.9M
Jun 30, 2026
488,654 sh · $28.35
Bertolini Mark T10b5-1
Chief Executive Officer · Director
−$3.9M
Jun 30, 2026
135,590 sh · $28.97
Bertolini Mark T10b5-1
Chief Executive Officer · Director
−$16.2M
Jun 29, 2026
555,826 sh · $29.17
Bertolini Mark T10b5-1
Chief Executive Officer · Director
−$1.8M
Jun 29, 2026
58,926 sh · $30.08
Bertolini Mark T10b5-1
Chief Executive Officer · Director
−$12.8M
Jun 26, 2026
441,373 sh · $29.11
Bertolini Mark T10b5-1
Chief Executive Officer · Director
−$4.5M
Jun 26, 2026
149,795 sh · $29.79
Bertolini Mark T10b5-1
Chief Executive Officer · Director
−$17.1M
Jun 25, 2026
597,942 sh · $28.60
Bertolini Mark T10b5-1
Chief Executive Officer · Director
−$500.2K
Jun 25, 2026
17,200 sh · $29.08
Schlosser Mario10b5-1
Director
−$8.3M
Jun 23, 2026
286,988 sh · $28.95
Schlosser Mario10b5-1
Director
−$17.5M
Jun 23, 2026
591,213 sh · $29.58
Schlosser Mario10b5-1
Director
−$54.1K
Jun 23, 2026
1,799 sh · $30.09
Schlosser Mario10b5-1
Director
−$472.1K
Jun 23, 2026
16,307 sh · $28.95
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Sep 18, 2026 | Wittman Vanessa Ames10b5-1Director | 25,000 | $32.24 | −$806K |
| Sep 03, 2026 | Liang Janet10b5-1President, Oscar Insurance | 10,360 | $31.45 | −$325.8K |
| Sep 03, 2026 | Baltrus Victoria10b5-1Chief Accounting Officer | 958 | $31.45 | −$30.1K |
| Sep 03, 2026 | Blackley Richard Scott10b5-1Chief Financial Officer | 28,869 | $31.45 | −$907.9K |
| Sep 03, 2026 | McAnaney Adam10b5-1Chief Legal Officer | 9,092 | $31.45 | −$285.9K |
| Sep 03, 2026 | Schlosser Mario10b5-1Director | 31,422 | $31.45 | −$988.2K |
| Aug 28, 2026 | Schlosser MarioDirector | 150,000 | $30.79 | −$4.6M |
| Aug 27, 2026 | Schlosser MarioDirector | 600,000 | $30.34 | −$18.2M |
| Aug 18, 2026 | Blackley Richard ScottChief Financial Officer | 18,750 | $31.74 | −$595.1K |
| Jul 01, 2026 | Schlosser Mario10b5-1Director | 3,600 | $29.50 | −$106.2K |
| Jul 01, 2026 | Schlosser Mario10b5-1Director | 13,672 | $30.80 | −$421.1K |
| Jul 01, 2026 | Schlosser Mario10b5-1Director | 30,228 | $31.65 | −$956.7K |
| Jun 30, 2026 | Bertolini Mark T10b5-1Chief Executive Officer · Director | 488,654 | $28.35 | −$13.9M |
| Jun 30, 2026 | Bertolini Mark T10b5-1Chief Executive Officer · Director | 135,590 | $28.97 | −$3.9M |
| Jun 29, 2026 | Bertolini Mark T10b5-1Chief Executive Officer · Director | 555,826 | $29.17 | −$16.2M |
| Jun 29, 2026 | Bertolini Mark T10b5-1Chief Executive Officer · Director | 58,926 | $30.08 | −$1.8M |
| Jun 26, 2026 | Bertolini Mark T10b5-1Chief Executive Officer · Director | 441,373 | $29.11 | −$12.8M |
| Jun 26, 2026 | Bertolini Mark T10b5-1Chief Executive Officer · Director | 149,795 | $29.79 | −$4.5M |
| Jun 25, 2026 | Bertolini Mark T10b5-1Chief Executive Officer · Director | 597,942 | $28.60 | −$17.1M |
| Jun 25, 2026 | Bertolini Mark T10b5-1Chief Executive Officer · Director | 17,200 | $29.08 | −$500.2K |
| Jun 23, 2026 | Schlosser Mario10b5-1Director | 286,988 | $28.95 | −$8.3M |
| Jun 23, 2026 | Schlosser Mario10b5-1Director | 591,213 | $29.58 | −$17.5M |
| Jun 23, 2026 | Schlosser Mario10b5-1Director | 1,799 | $30.09 | −$54.1K |
| Jun 23, 2026 | Schlosser Mario10b5-1Director | 16,307 | $28.95 | −$472.1K |
SEC Form 4 data, Q3 2024 to Q2 2026
OSCR insider trading by quarter
Between Jul 01, 2024 and Jun 30, 2026, 13 insiders traded OSCR on the open market: 8 purchases worth $35M and 84 sales worth $104.4M, 43 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 1 purchase ($11.9M) and 46 sales ($93.3M), by 6 insiders.
| Quarter | Bought | Sold | Insiders |
|---|---|---|---|
| Q2 2026 | +$11.9M1 buy | −$72.1M28 sales · all on a plan | |
| Q1 2026 | — | −$6.3M9 sales · all on a plan | |
| Q4 2025 | — | −$7.6M8 sales · 6 on a plan | |
| Q3 2025 | — | −$7.3M1 sale | |
| Q2 2025 | — | −$410.8K1 sale | |
| Q1 2025 | — | — | |
| Q4 2024 | +$23.1M7 buys | −$3.1M17 sales | |
| Q3 2024 | — | −$7.6M20 sales |
- Largest purchase
- +$11.9M of OSCR by Bertolini Mark T (Chief Executive Officer · Director) on Apr 06, 2026.
- Largest sale
- −$17.5M of OSCR by Schlosser Mario (Director) on Jun 23, 2026, under a 10b5-1 plan.
Open-market transactions through Jun 30, 2026most recent first
Schlosser Mario10b5-1
Director
−$993.7K
Jun 23, 2026
33,592 sh · $29.58
Schlosser Mario10b5-1
Director
−$993.6K
Jun 23, 2026
33,591 sh · $29.58
Schlosser Mario10b5-1
Director
−$944K
Jun 23, 2026
31,912 sh · $29.58
Schlosser Mario10b5-1
Director
−$472.1K
Jun 23, 2026
16,306 sh · $28.95
Schlosser Mario10b5-1
Director
−$448.5K
Jun 23, 2026
15,491 sh · $28.95
Schlosser Mario10b5-1
Director
−$3.1K
Jun 23, 2026
102 sh · $30.09
Schlosser Mario10b5-1
Director
−$2.9K
Jun 23, 2026
97 sh · $30.09
Schlosser Mario10b5-1
Director
−$531.6K
Jun 02, 2026
24,452 sh · $21.74
Blackley Richard Scott10b5-1
Chief Financial Officer
−$493.6K
Jun 02, 2026
22,706 sh · $21.74
Schlosser Mario10b5-1
Director
−$217K
Jun 02, 2026
9,668 sh · $22.45
Blackley Richard Scott10b5-1
Chief Financial Officer
−$201.5K
Jun 02, 2026
8,977 sh · $22.45
Liang Janet10b5-1
President, Oscar Insurance
−$194.4K
Jun 02, 2026
8,940 sh · $21.74
McAnaney Adam10b5-1
Chief Legal Officer
−$153.6K
Jun 02, 2026
7,065 sh · $21.74
Liang Janet10b5-1
President, Oscar Insurance
−$79.4K
Jun 02, 2026
3,535 sh · $22.45
McAnaney Adam10b5-1
Chief Legal Officer
−$62.7K
Jun 02, 2026
2,794 sh · $22.45
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Schlosser Mario10b5-1Director | 33,592 | $29.58 | −$993.7K |
| Jun 23, 2026 | Schlosser Mario10b5-1Director | 33,591 | $29.58 | −$993.6K |
| Jun 23, 2026 | Schlosser Mario10b5-1Director | 31,912 | $29.58 | −$944K |
| Jun 23, 2026 | Schlosser Mario10b5-1Director | 16,306 | $28.95 | −$472.1K |
| Jun 23, 2026 | Schlosser Mario10b5-1Director | 15,491 | $28.95 | −$448.5K |
| Jun 23, 2026 | Schlosser Mario10b5-1Director | 102 | $30.09 | −$3.1K |
| Jun 23, 2026 | Schlosser Mario10b5-1Director | 97 | $30.09 | −$2.9K |
| Jun 02, 2026 | Schlosser Mario10b5-1Director | 24,452 | $21.74 | −$531.6K |
| Jun 02, 2026 | Blackley Richard Scott10b5-1Chief Financial Officer | 22,706 | $21.74 | −$493.6K |
| Jun 02, 2026 | Schlosser Mario10b5-1Director | 9,668 | $22.45 | −$217K |
| Jun 02, 2026 | Blackley Richard Scott10b5-1Chief Financial Officer | 8,977 | $22.45 | −$201.5K |
| Jun 02, 2026 | Liang Janet10b5-1President, Oscar Insurance | 8,940 | $21.74 | −$194.4K |
| Jun 02, 2026 | McAnaney Adam10b5-1Chief Legal Officer | 7,065 | $21.74 | −$153.6K |
| Jun 02, 2026 | Liang Janet10b5-1President, Oscar Insurance | 3,535 | $22.45 | −$79.4K |
| Jun 02, 2026 | McAnaney Adam10b5-1Chief Legal Officer | 2,794 | $22.45 | −$62.7K |
From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.
Oscar Health, Inc. company record
- SEC industry classification
- Hospital & Medical Service Plans
- Headquarters
- New York, NY
- Incorporated in
- DE
- Listed on
- NYSE
- SEC Central Index Key
- 0001568651
- Previously filed as
- Mulberry Health Inc.
Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.
After insiders bought OSCR
What the stock actually did in the 90 days following each open-market purchase
Don't check OSCR — let it ping you
Get told the moment an insider moves on OSCR
Pro watches Oscar Health, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add OSCR to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.
The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.
How to read OSCR insider activity
- Open-market purchase (code P)
- An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
- Grants and option exercises (codes A, M)
- Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
- Cluster buy
- Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.
Other Health Care tickers
Questions
- Are OSCR insiders buying or selling?
- Between Jun 23, 2026 and Sep 18, 2026, 7 Oscar Health, Inc. insiders made no open-market purchases and 24 sales worth $125.2M, a net sale of $125.2M. 21 of the sales were pre-scheduled under a Rule 10b5-1 plan.
- How much OSCR stock have insiders bought and sold in the last two years?
- Between Jul 01, 2024 and Jun 30, 2026, 13 Oscar Health, Inc. insiders made 8 open-market purchases worth $35M and 84 sales worth $104.4M. 43 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 1 purchase ($11.9M) and 46 sales ($93.3M). The largest purchase was Bertolini Mark T buying $11.9M on Apr 06, 2026. The largest sale was Schlosser Mario selling $17.5M on Jun 23, 2026.
- What was the largest recent OSCR insider trade?
- Schlosser Mario (Director) sold $18.2M of OSCR stock on Aug 27, 2026 at about $30.34 a share.
- When did an insider last buy OSCR shares?
- No open-market purchase by a Oscar Health, Inc. insider appears in the filings from Jun 23, 2026 to Sep 18, 2026 — every recorded open-market transaction in that period was a sale. Before that, the most recent purchase in SEC's data was Bertolini Mark T buying $11.9M on Apr 06, 2026.
- Where does OSCR insider trading data come from?
- From the Form 4 filings Oscar Health, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.
Get the free Insider Brief
Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.